Heart failure trials in South Korea

In South Korea 56 Also abroad 1261

56 trials · From ClinicalTrials.gov, checked 10 November 2026. Ask the study team whether a trial fits you.

No phaseTaking people
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
Where
Busan, Cheongju-si, Daegu, Daejeon, Gwangju, Gyeonggi-do, Jeonju, Seongnam-si, Seoul, Suwon, Yangsan
People
20,000 worldwide
Run by
Medtronic
See details and how to joinNCT00271180
Phase 2/3Taking people
Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036)
Where
Pusan, Seoul
Age
29 days to 17 years
People
342 worldwide
Run by
Merck Sharp & Dohme LLC
See details and how to joinNCT05714085 · EU 2022-501238-52-00
No phaseTaking people
AI-Based Cardiac Analysis Using 12-Lead and 1-Lead ECG
Where
Incheon
Age
19 years and over
People
300
Run by
Inha University Hospital
See details and how to joinNCT07844434
Phase 3Taking people
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
Where
Daejeon, Gwangju, Seongnam-si, Gyeonggi-do, Seoul, Wonju-si, Gangwon-do
Age
18 years to 99 years
People
5,056 worldwide
Run by
Amgen
See details and how to joinNCT07037459
Phase 3Taking people
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
Where
Bucheon-si, Busan, Cheongju-si, Daegu, Daejeon, Deagu, Gwangju, Incheon, Seongnam, Seoul, Wonju-si, Gangwon State, Yangsan
Age
18 years and over
People
6,712 worldwide
Run by
Boehringer Ingelheim
See details and how to joinNCT06424288 · EU 2023-509706-30-00
Phase 3Taking people
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
Where
Busan, Gwangju, Incheon, Seongnam, Seoul, Wŏnju
Age
18 years and over
People
4,200 worldwide
Run by
Boehringer Ingelheim
See details and how to joinNCT06935370 · EU 2024-519525-38-00
Phase 3Taking people
A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Children and Young Adults With Heart Failure and Left Ventricular Systolic Dysfunction
Where
Seoul, Yangsan
Age
Up to 18 years
People
117 worldwide
Run by
Bayer
See details and how to joinNCT07192952 · EU 2024-519830-22-00
No phaseTaking people
Routine Versus Provisional Distal Perfusion Catheter Placement in Patients Undergoing Mechanical Circulatory Support
Where
Changwon, Incheon, Seoul
Age
19 years and over
People
500
Run by
Samsung Medical Center
See details and how to joinNCT07482865
Phase 3Taking people
Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
Where
Bucheon-si, Cheongju-si, Daegu, Seongnam-si, Seoul, Suwon, Wŏnju, Yangsan
Age
40 years and over
People
11,300 worldwide
Run by
AstraZeneca
See details and how to joinNCT06677060 · EU 2024-514506-32-00
Phase 3Taking people
CLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine Called Coramitug (NNC6019-0001) in People With Heart Failure Due to Transthyretin Amyloid (ATTR) Amyloidosis
Where
Busan, Seongnam-si, Seoul
Age
18 years and over
People
1,280 worldwide
Run by
Novo Nordisk A/S
See details and how to joinNCT07207811
Phase 3Taking people
A Study to Learn More About How Well Finerenone Works, How Safe it is, and How it Moves Into, Through, and Out of the Body Compared to Placebo When Taken With Standard Treatment in Children With Heart Failure and Left Ventricular Systolic Dysfunction
Where
Jongno, Seodaemun, Seoul, Yangsan
Age
6 months to 17 years
People
111 worldwide
Run by
Bayer
See details and how to joinNCT07188805 · EU 2024-519829-38-00
Phase 3Taking people
Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function
Where
Anyang-si, Bucheon-si, Busan, Cheongju-si, Daegu, Daejeon, Gwangju, Gwangmyeong, Incheon, Junggu, Seongnam-si, Seoul, Uijeongbu-si, Wŏnju, Yangsan
Age
18 years to 130 years
People
3,850 worldwide
Run by
AstraZeneca
See details and how to joinNCT06307652 · EU 2023-508162-15-00
Phase 1Taking people
A Phase I Study of Allogeneic Myocardium-Derived Mesenchymal Stem Cells (HB1011) in Patients With Ischemic Cardiomyopathy
Where
Seongnam-si
Age
19 years to 85 years
People
12
Run by
HieraBio Inc.
See details and how to joinNCT07861035
Phase 2Taking people
A Research Study Comparing Different Doses of CDR132L With Placebo on the Structure and Function of the Heart in People With Heart Failure With Preserved Ejection Fraction and Left Ventricular Hypertrophy
Where
Cheongju-si, Daegu, Gangwon-do, Seongnam-si, Gyeonggi-do, Seoul
Age
40 years to 84 years
People
200 worldwide
Run by
Novo Nordisk A/S
See details and how to joinNCT06979362 · EU 2024-515796-35-00
No phaseTaking people
AI-Powered Electrocardiography for Diagnosis and Prognostic Prediction in Cardiovascular Disease (AI-CVD): Multicenter Retrospective Study
Where
Incheon
Age
18 years and over
People
10,000
Run by
Inha University Hospital
See details and how to joinNCT07856472
Phase 3Taking people
A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF
Where
Busan, Daegu, Daejeon, Gwangju, Gyeonggi-do, Incheon, Seongbuk-Gu, Seoul, Suwon, Uijeongbu-si, Yangsan
Age
18 years and over
People
6,950 worldwide
Run by
AstraZeneca
See details and how to joinNCT07761117 · EU 2026-526304-79-00
Phase 3Taking people
A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
Where
Bucheon-si, Busan, Cheongju-si, Daegu, Daejeon, Gangneung, Gwangju, Incheon, Seoul, Wŏnju
Age
18 years and over
People
5,200 worldwide
Run by
Colorado Prevention Center
See details and how to joinNCT06008197
No phaseTaking people
Novel Technologies to Improve Echocardiographic Estimates of Left Ventricular Filling Pressure in Heart Failure Combined With Atrial Fibrillation
Where
Seoul
Age
18 years and over
People
400 worldwide
Run by
Oslo University Hospital
See details and how to joinNCT07436299
Phase 4Taking people
Delayed Initiation of ARNI and SGLT2i in Heart Failure With Corrected Aetiology (DELAY-HF), Pilot Study
Where
Daegu, Seongnam-si, Seoul, Suwon
Age
18 years and over
People
80
Run by
Kyungsub Song
See details and how to joinNCT07572032
Phase 4Taking people
STEPwise De-escalation and Optimizing Withdrawal of ARNI and SGLT2i in Normalized Heart Failure
Where
Daegu, Seongnam-si, Seoul, Suwon, Yangsan
Age
19 years and over
People
80
Run by
Kyungsub Song
See details and how to joinNCT07631156
Phase 4Taking people
Clinical Impact of SGLT2 Inhibitor After DC Cardioversion in Persistent AF With HFpEF
Where
Seoul
Age
19 years and over
People
200
Run by
Samsung Medical Center
See details and how to joinNCT07776054
Phase 3Taking people
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
Where
Anyang-si, Daegu, Daejeon, Gwangju, Incheon, Seongnam-si, Seoul, Suwon, Uijeongbu-si, Wŏnju, Yangsan
Age
18 years and over
People
5,610 worldwide
Run by
Novo Nordisk A/S
See details and how to joinNCT07567001 · EU 2025-523717-29-00
No phaseNot yet taking people in South Korea
Cardioprotective Effects of SGLT2 Inhibitors and GLP-1 Receptor Agonists in Korean Patients With Type 2 Diabetes
Where
Hwaseong-si
Age
19 years and over
People
100
Run by
Dongtan Sacred Heart Hospital
See details and how to joinNCT07770737
No phaseTaking people
AI ECG Algorithm for Detecting LV Systolic Dysfunction
Where
Suwon
Age
19 years and over
People
1,500
Run by
Ajou University School of Medicine
See details and how to joinNCT07636759
No phaseTaking people
Early Detection and IntervenTion in Heart Failure
Where
Seoul
Age
65 years and over
People
18,000 worldwide
Run by
University Hospital, Basel, Switzerland
See details and how to joinNCT07731490